Nature Communications (Dec 2021)

Convergent use of phosphatidic acid for hepatitis C virus and SARS-CoV-2 replication organelle formation

  • Keisuke Tabata,
  • Vibhu Prasad,
  • David Paul,
  • Ji-Young Lee,
  • Minh-Tu Pham,
  • Woan-Ing Twu,
  • Christopher J. Neufeldt,
  • Mirko Cortese,
  • Berati Cerikan,
  • Yannick Stahl,
  • Sebastian Joecks,
  • Cong Si Tran,
  • Christian Lüchtenborg,
  • Philip V’kovski,
  • Katrin Hörmann,
  • André C. Müller,
  • Carolin Zitzmann,
  • Uta Haselmann,
  • Jürgen Beneke,
  • Lars Kaderali,
  • Holger Erfle,
  • Volker Thiel,
  • Volker Lohmann,
  • Giulio Superti-Furga,
  • Britta Brügger,
  • Ralf Bartenschlager

DOI
https://doi.org/10.1038/s41467-021-27511-1
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 15

Abstract

Read online

Double membrane vesicles (DMV) are used as replication organelles by several RNA viruses. Applying proteomics and lipidomics, Tabata and Prasad et al. find that two cellular acyltransferases (AGPAT1/2), responsible for synthesis of phosphatidic acid, play a role in the DMV-biogenesis of HCV and SARS-CoV-2, highlighting a common biogenesis mechanism for evolutionary distant positive-strand RNA viruses.